Guest Post — What Does Commercial Adoption Mean for the Preprint Movement?
Today’s guest bloggers suggest that the involvement of commercial publishers is not unequivocally bad for preprints, and provide some optimism about open access as a whole.
Mahesh Miikael Karnani (ORCID, LinkedIn) is a neuroscientist and group leader at the University of Edinburgh, where he leads the Drivelab research group. They are both managing board members of PCI Neuroscience, a community-led initiative that provides transparent, free peer reviews for neuroscience preprints. The views expressed in this piece are their own and not necessarily those of PCI Neuroscience, PCI, or their respective employers.